Tag:
bevirimat
Latest Headlines
Latest Headlines
Myriad acquires HIV drug in $7M deal
Myriad Pharmaceuticals is paying $7 million to acquire an experimental HIV therapy from Panacos. Billed as a new class of HIV drug, bevirimat inhibits HIV isolates that are resistant to currently
